News & Perspective

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Jul 17, 2009

Jul 17, 2009

CDC braces for back-to-school flu spike, addresses vaccine worries

Jul 17 2009 (CIDRAP News) – Novel flu activity is still going strong but dropped for the third week in a row, the US Centers for Disease Control and Prevention (CDC) said today during a media briefing that also sought to calm fears about vaccine availability.

Aug 21, 2009

Aug 21, 2009

First H1N1 vaccine trial data expected in mid-September

(CIDRAP News) – Federal health officials today said the first results of novel H1N1 vaccine trials—needed for determining the number and size of doses people will get—are expected in mid-September.

Two trials in adult and elderly volunteers started Aug 7 and are now almost fully enrolled, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), at a press teleconference.

Aug 06, 2010

Aug 06, 2010

Shelf life for remaining H1N1 vaccine to be shortened

(CIDRAP News) – About 16 million remaining doses of monovalent 2009 H1N1 vaccine made by Sanofi Pasteur and packaged in multidose vials will expire sooner than expected, but expiration dates have not yet been determined, federal health officials and the company said today.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»